Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1104PDF: 502HTML: 175 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3557PDF: 870HTML: 6702 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1573PDF: 574HTML: 217 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4610PDF: 1305HTML: 1901Untitled: 178Untitled: 174 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2346PDF: 1384HTML: 1973 -
EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS
3113PDF: 960HTML: 1887Untitled: 163Untitled: 166Untitled: 162Untitled: 166Untitled: 158 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3118PDF: 885HTML: 1528Fig.1 CHL-R paper: 209Fig 2 CHL-R paper: 232 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4267PDF: 1743HTML: 1100 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4025PDF: 1915HTML: 5211Table 1: 181 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1343HTML: 382PDF: 810 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2777PDF: 1000HTML: 5509 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2297PDF: 976HTML: 7609Untitled: 270Fig2: 180Fig3: 164Fig4: 176 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1745PDF: 814HTML: 220 -
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients
1219PDF: 720HTML: 363 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1362PDF: 812HTML: 3111 -
BETA-GLOBIN GENE MUTATIONS IN TURKISH CHILDREN WITH BETA-THALASSEMIA: RESULTS FROM A SINGLE CENTER STUDY
1607PDF: 683HTML: 1620Beta-globin Gene Mutations in Turkish Children with Beta-Thalassemia: Results from a Single Center Study: 181 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1163PDF: 1051HTML: 184 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
933PDF: 1199HTML: 99 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4687PDF: 1541HTML: 2243Untitled: 202Untitled: 217Untitled: 226Untitled: 209Untitled: 210 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3024PDF: 867HTML: 7158Kost Fig1: 176Kost Fig 2: 174Kost Fig3: 169Kost Fig 4: 183Kost Fig5: 181Kost fig 6: 167 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1480PDF: 535HTML: 700 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4006PDF: 3309HTML: 191 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
951PDF: 1119Suppl. Files: 137HTML: 65 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1722PDF: 867HTML: 368Fig1: 227Fig.2: 247Fig. 3: 174Fig. 5: 191Fig. 4: 218 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3848Suppl. Files: 1089PDF: 1052Html: 165 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1439PDF: 756HTML: 196 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1724PDF: 1275HTML: 11475Figure1: 167Figure 2: 169 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4062PDF: 1569HTML: 908 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1929PDF: 735HTML: 686 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3489PDF: 1536HTML: 69







